FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug ...
Glenmark Pharmaceuticals is set to launch an 8.4 per cent Sodium Bicarbonate Injection in the United States. This generic ...
Glenmark Pharma to launch generic Sodium Bicarbonate Injection in the US for treating metabolic acidosis. Distribution starts ...
President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how ...
Having seen Congress spend money to onshore semiconductor production, pharma groups are pushing for similar incentives for ...
Developers of biosimilars -- medicines that are near-identical copies of biologic drugs -- will no longer be required to conduct clinical trials to prove effectiveness.
Trump administration officials pledged Monday that major reforms for biosimilar drug approvals will expand access and lower ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback